Accord Pharmaceuticals Limited IPO 2080 in Nepal


Accord Pharmaceuticals Limited is an emerging Nepalese pharma venture committed to building a healthier community with quality products that comply with stringent quality standards. Formed by a group of professionals with more than a decade of experience in the pharmaceutical and healthcare business. The plant has state of art manufacturing facility at Mahalaxmi-8, Lubhu, Bishnudol, Lalitpur with a total built-up area of 60,000 sq. ft. with the tablet, capsule, liquid, and semi-solid sections.

The manufacturing facility has been created on a clean room concept conforming to statutory regulations like WHO-GMP & EU-GMP. Accord Pharmaceuticals Limited is a pharmaceutical manufacturing company that was registered in 2013. Its main office is located in Kathmandu. The main purpose of the establishment of the company was to provide pharmaceutical goods to the whole country in affordable ways and it is able to deliver them for a long time. Mr Krishna Prasad Kandel holds 24 per cent of the shares while Mr Bishal Pandit and Shreedhar Khanal hold 33 and 5 per cent each.

Accord pharmaceuticals limited is going to float an IPO worth 76,900,000 rupees having 76,909 shares to the general public very soon. The company has appointed Global Ime Capital as its issue manager for this IPO. The issue manager does all the things for the company until the shares are transferred to the shareholders.

The managing director of accord pharmaceutical limited and CEO of Global Ime Capital has signed the contract to issue it as issue manager. It will soon announce a date for the application of IPO for the general public. It is better to apply for only 10 kitta of IPO as it has very less stocks. It is a very reputed company and it may give us great returns in the future so it is the stock to watch for in the future.

IPO Details of Accord Pharmaceuticals

Name of CompanyAccord Pharmaceuticals Limited
No. of share7,06,909
Amount of IssueRs.7,06,90,900
Issue ManagerGlobal IME Capital Limited

Leave a Comment

Your email address will not be published. Required fields are marked *